nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR2A—chronic obstructive pulmonary disease	0.922	1	CbGaD
Cinitapride—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.0286	0.623	CbGeAlD
Cinitapride—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.0104	0.226	CbGeAlD
Cinitapride—HTR4—Serotonin receptors—HTR2A—chronic obstructive pulmonary disease	0.00359	0.112	CbGpPWpGaD
Cinitapride—HTR4—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.00205	0.0638	CbGpPWpGaD
Cinitapride—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.00175	0.0381	CbGeAlD
Cinitapride—HTR4—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.00172	0.0536	CbGpPWpGaD
Cinitapride—HTR4—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.0016	0.0499	CbGpPWpGaD
Cinitapride—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.00154	0.0335	CbGeAlD
Cinitapride—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00141	0.0306	CbGeAlD
Cinitapride—HTR4—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.0014	0.0437	CbGpPWpGaD
Cinitapride—HTR4—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.00134	0.0419	CbGpPWpGaD
Cinitapride—HTR2A—trachea—chronic obstructive pulmonary disease	0.00129	0.0281	CbGeAlD
Cinitapride—HTR1A—Serotonin receptors—HTR2A—chronic obstructive pulmonary disease	0.00114	0.0356	CbGpPWpGaD
Cinitapride—HTR2A—lung—chronic obstructive pulmonary disease	0.000927	0.0202	CbGeAlD
Cinitapride—HTR4—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.000709	0.0221	CbGpPWpGaD
Cinitapride—HTR1A—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.000651	0.0203	CbGpPWpGaD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000629	0.0196	CbGpPWpGaD
Cinitapride—HTR2A—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.000562	0.0175	CbGpPWpGaD
Cinitapride—HTR1A—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000547	0.0171	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000539	0.0168	CbGpPWpGaD
Cinitapride—HTR1A—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000509	0.0159	CbGpPWpGaD
Cinitapride—HTR2A—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000473	0.0147	CbGpPWpGaD
Cinitapride—HTR1A—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000428	0.0133	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000411	0.0128	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.000398	0.0124	CbGpPWpGaD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000395	0.0123	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000338	0.0105	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000336	0.0105	CbGpPWpGaD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000309	0.00962	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000302	0.00942	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000288	0.00897	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000265	0.00827	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000264	0.00824	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000261	0.00815	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000258	0.00803	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.00025	0.00779	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000239	0.00747	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000232	0.00723	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00023	0.00718	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000229	0.00715	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000216	0.00673	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000211	0.00657	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000207	0.00645	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000204	0.00635	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000201	0.00628	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.0002	0.00624	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000173	0.00539	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000172	0.00535	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000166	0.00517	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000163	0.00509	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000154	0.00481	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000148	0.00462	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000147	0.00458	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000146	0.00454	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000143	0.00447	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000132	0.00412	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000131	0.00407	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.00013	0.00406	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000126	0.00392	CbGpPWpGaD
Cinitapride—HTR2A—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000125	0.00391	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000124	0.00388	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000124	0.00388	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000118	0.00368	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000114	0.00355	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000113	0.00352	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000112	0.0035	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000109	0.00338	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000108	0.00336	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000107	0.00334	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000103	0.00322	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	9.82e-05	0.00306	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	9.62e-05	0.003	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	9.3e-05	0.0029	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	9.25e-05	0.00288	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	9.16e-05	0.00286	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.1e-05	0.00284	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	9.07e-05	0.00283	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	8.7e-05	0.00271	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.46e-05	0.00264	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.41e-05	0.00262	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.32e-05	0.00259	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	8.31e-05	0.00259	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	8.2e-05	0.00256	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	7.91e-05	0.00247	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	7.84e-05	0.00244	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.81e-05	0.00243	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	7.52e-05	0.00234	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.38e-05	0.0023	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.37e-05	0.0023	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.32e-05	0.00228	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	7.19e-05	0.00224	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	7.08e-05	0.00221	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.03e-05	0.00219	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.98e-05	0.00218	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.71e-05	0.00209	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	6.54e-05	0.00204	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.48e-05	0.00202	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.41e-05	0.002	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.38e-05	0.00199	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	6.38e-05	0.00199	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	6.37e-05	0.00199	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.34e-05	0.00198	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	6.33e-05	0.00197	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.32e-05	0.00197	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.1e-05	0.0019	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	5.79e-05	0.00181	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.67e-05	0.00177	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.6e-05	0.00175	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	5.46e-05	0.0017	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.2e-05	0.00162	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.1e-05	0.00159	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.91e-05	0.00153	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.67e-05	0.00145	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.63e-05	0.00144	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.49e-05	0.0014	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.45e-05	0.00139	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	4.43e-05	0.00138	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.4e-05	0.00137	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.25e-05	0.00133	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.25e-05	0.00132	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.21e-05	0.00131	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.14e-05	0.00129	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4e-05	0.00125	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.96e-05	0.00124	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.96e-05	0.00123	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.77e-05	0.00118	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.76e-05	0.00117	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.63e-05	0.00113	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.62e-05	0.00113	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.59e-05	0.00112	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.58e-05	0.00111	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.42e-05	0.00107	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.42e-05	0.00107	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.41e-05	0.00106	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.41e-05	0.00106	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.29e-05	0.00103	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.25e-05	0.00101	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.06e-05	0.000955	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.9e-05	0.000903	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.81e-05	0.000876	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.76e-05	0.000859	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.69e-05	0.000839	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.5e-05	0.00078	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.48e-05	0.000775	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.33e-05	0.000725	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.31e-05	0.000722	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.24e-05	0.000698	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.22e-05	0.000692	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.15e-05	0.000669	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.12e-05	0.00066	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.03e-05	0.000633	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.02e-05	0.000629	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.94e-05	0.000606	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.93e-05	0.000603	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.92e-05	0.000598	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.81e-05	0.000563	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.76e-05	0.000547	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.74e-05	0.000544	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.56e-05	0.000486	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.48e-05	0.000463	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.42e-05	0.000442	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.35e-05	0.000422	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.28e-05	0.0004	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.22e-05	0.000382	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.2e-05	0.000374	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.17e-05	0.000364	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.14e-05	0.000356	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.09e-05	0.000338	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.04e-05	0.000323	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.86e-06	0.000307	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.75e-06	0.000304	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.38e-06	0.000292	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.95e-06	0.000279	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.77e-06	0.000273	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.42e-06	0.000263	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.73e-06	0.000241	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.58e-06	0.000236	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.36e-06	0.00023	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.74e-06	0.00021	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.36e-06	0.000198	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.82e-06	0.000182	CbGpPWpGaD
